NYSEAMERICAN : PMI
Picard Medical, Inc. — Financial statements
Healthcare · Medical Devices · United States
Last price 8.35 USD (Oct 30, 2026, 4:00 PM EST) · Market cap 19.53M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Picard Medical, Inc. (PMI) reported revenue of 6.30M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | 6.30M | 4.94M | 4.39M | 5.04M | 4.11M |
| Cost of Revenue | 5.13M | 5.14M | 4.50M | 7.35M | 9.10M |
| Gross Profit | 1.17M | -204.00K | -112.00K | -2.31M | -4.99M |
| Selling, General & Admin | 12.04M | 10.00M | 10.22M | 10.98M | 4.18M |
| Research & Development | 4.77M | 3.05M | 3.38M | 2.21M | 1.90M |
| Operating Expenses | 16.80M | 13.05M | 13.60M | 13.19M | 6.08M |
| Operating Income | -15.63M | -13.26M | -13.71M | -15.50M | -11.07M |
| Interest Expense | -2.50M | -5.39M | -3.07M | -140.00K | -5.00K |
| Interest & Investment Income | 2.00K | 9.00K | |||
| Other Non Operating Income (Expenses) | -7.32M | -9.33M | -4.29M | 69.00K | -94.00K |
| EBT Excluding Unusual Items | -25.46M | -27.98M | -21.07M | -15.57M | -11.16M |
| Other Unusual Items | -2.53M | 1.02M | |||
| Pretax Income | -27.98M | -26.97M | -21.07M | -15.57M | -11.16M |
| Income Tax Expense | 11.00K | 35.00K | -15.00K | -2.00K | 11.00K |
| Net Income | -27.99M | -27.00M | -21.05M | -15.57M | -11.17M |
| Preferred Dividends & Other Adjustments | -1.58M | 2.68M | 2.43M | 1.50M | |
| Net Income to Common | -26.42M | -27.00M | -23.74M | -18.00M | -12.67M |
| Shares Outstanding (Basic) | 1.48M | 724.66K | 158.87K | 158.87K | 111.83K |
| Shares Outstanding (Diluted) | 1.48M | 724.66K | 158.87K | 158.87K | 111.83K |
| EPS (Basic) | -17.88 | -37.26 | -149.41 | -113.31 | -113.30 |
| EPS (Diluted) | -17.88 | -37.26 | -149.41 | -113.31 | -113.30 |
| Free Cash Flow | -16.07M | -15.67M | -11.87M | -10.64M | -10.75M |
| Free Cash Flow Per Share | -10.88 | -21.63 | -74.74 | -66.98 | -96.15 |
| Gross Margin | 18.60% | -4.13% | -2.55% | -45.83% | -121.27% |
| Operating Margin | -248.09% | -268.36% | -312.27% | -307.40% | -269.07% |
| Profit Margin | -419.32% | -546.60% | -540.58% | -356.97% | -308.05% |
| Free Cash Flow Margin | -255.06% | -317.27% | -270.42% | -211.01% | -261.42% |
| EBITDA | -15.46M | -13.09M | -13.49M | -14.92M | -10.52M |
| EBITDA Margin | -245.37% | -265.06% | -295.80% | -255.82% | |
| D&A For EBITDA | 172.00K | 163.00K | 226.00K | 585.00K | 545.00K |
| EBIT | -15.63M | -13.26M | -13.71M | -15.50M | -11.07M |
| EBIT Margin | -248.09% | -268.36% | -269.07% | ||
| Revenue as Reported | 6.30M | 4.94M | 4.39M | 5.04M | 4.11M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Cash & Equivalents | 38.00K | 7.45M | 96.00K | 244.00K | 152.00K |
| Cash & Short-Term Investments | 38.00K | 7.45M | 96.00K | 244.00K | 152.00K |
| Accounts Receivable | 614.00K | 623.00K | 513.00K | 629.00K | 882.00K |
| Other Receivables | 112.00K | 2.76M | |||
| Receivables | 614.00K | 757.00K | 625.00K | 741.00K | 3.64M |
| Inventory | 5.97M | 7.30M | 8.12M | 6.89M | 7.33M |
| Prepaid Expenses | 970.00K | 1.22M | 955.00K | 883.00K | 1.00M |
| Restricted Cash | 4.00M | ||||
| Total Current Assets | 7.59M | 20.73M | 9.79M | 8.76M | 12.12M |
| Property, Plant & Equipment | 495.00K | 698.00K | 1.10M | 1.31M | 1.93M |
| Goodwill | 615.00K | 615.00K | 615.00K | 615.00K | 615.00K |
| Other Intangible Assets | 465.00K | 509.00K | 596.00K | 684.00K | 771.00K |
| Total Assets | 9.17M | 22.55M | 12.11M | 11.37M | 15.44M |
| Accounts Payable | 3.32M | 2.08M | 5.29M | 3.08M | 1.39M |
| Accrued Expenses | 956.00K | 1.36M | 2.37M | 1.76M | 720.00K |
| Short-Term Debt | 1.27M | 6.45M | 5.15M | 4.06M | 620.00K |
| Current Portion of Long-Term Debt | 14.83M | ||||
| Current Portion of Leases | 311.00K | 463.00K | 434.00K | 310.00K | 267.00K |
| Other Current Liabilities | 1.59M | 8.34M | 7.25M | ||
| Total Current Liabilities | 7.45M | 18.70M | 35.33M | 9.21M | 3.00M |
| Long-Term Debt | 4.28M | ||||
| Long-Term Leases | 64.00K | 517.00K | 762.00K | 1.07M | |
| Other Long-Term Liabilities | 670.00K | ||||
| Total Liabilities | 7.45M | 18.76M | 35.84M | 14.93M | 4.07M |
| Common Stock | 7.00K | 1.00K | 1.00K | ||
| Additional Paid-In Capital | 91.57M | 80.40M | 5.56M | 4.67M | 3.92M |
| Retained Earnings | -90.12M | -76.84M | -49.84M | -28.79M | -13.22M |
| Comprehensive Income & Other | 269.00K | 228.00K | 278.00K | 293.00K | 398.00K |
| Total Common Equity | 1.72M | 3.79M | -44.00M | -23.82M | -8.90M |
| Shareholders' Equity | 1.72M | 3.79M | -23.74M | -3.55M | 11.37M |
| Total Liabilities & Equity | 9.17M | 22.55M | 12.11M | 11.37M | 15.44M |
| Total Debt | 1.58M | 6.97M | 20.93M | 9.41M | 1.96M |
| Net Cash (Debt) | -1.54M | 476.00K | -20.83M | -9.17M | -1.81M |
| Net Cash Per Share | -1.04 | 0.66 | -131.12 | -57.70 | -16.16 |
| Filing Date Shares Outstanding | 2.34M | 1.50M | 165.93K | 158.87K | 111.83K |
| Total Common Shares Outstanding | 2.06M | 1.47M | 158.87K | 158.87K | 111.83K |
| Working Capital | 141.00K | 2.03M | -25.53M | -451.00K | 9.12M |
| Book Value Per Share | 0.83 | 2.57 | -276.96 | -149.91 | -79.55 |
| Tangible Book Value | 636.00K | 2.67M | -45.21M | -25.12M | -10.28M |
| Tangible Book Value Per Share | 0.31 | 1.81 | -284.58 | -158.09 | -91.95 |
| Machinery | 706.00K | 681.00K | 649.00K | 723.00K | 904.00K |
| Leasehold Improvements | 101.00K | 101.00K | 101.00K | 101.00K | 101.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Net Income | -27.99M | -27.00M | -21.05M | -15.57M | -11.17M |
| Depreciation & Amortization | 531.00K | 512.00K | 544.00K | 585.00K | 545.00K |
| Other Amortization | 2.16M | 4.53M | 2.39M | ||
| Loss (Gain) From Sale of Assets | 58.00K | ||||
| Stock-Based Compensation | 1.98M | 754.00K | 886.00K | 133.00K | 148.00K |
| Other Operating Activities | 10.43M | 8.74M | 4.40M | 879.00K | 1.68M |
| Change in Accounts Receivable | 676.00K | -120.00K | 116.00K | 253.00K | 210.00K |
| Change in Inventory | 461.00K | 390.00K | -1.33M | -446.00K | -1.59M |
| Change in Accounts Payable | -3.04M | -3.21M | 2.21M | 1.61M | 107.00K |
| Change in Other Net Operating Assets | -1.23M | -261.00K | -33.00K | 1.87M | -652.00K |
| Operating Cash Flow | -16.04M | -15.67M | -11.87M | -10.63M | -10.72M |
| Capital Expenditures | -26.00K | -7.00K | -29.00K | ||
| Other Investing Activities | -2.00K | -8.00K | |||
| Investing Cash Flow | -26.00K | -9.00K | -37.00K | ||
| Short-Term Debt Issued | 3.91M | 9.42M | 4.92M | ||
| Long-Term Debt Issued | 15.50M | 3.70M | 4.16M | 5.55M | |
| Total Debt Issued | 17.18M | 19.41M | 13.12M | 9.08M | 5.55M |
| Short-Term Debt Repaid | -8.19M | -1.32M | -880.00K | ||
| Long-Term Debt Repaid | -97.00K | -56.00K | -10.00K | -26.00K | |
| Total Debt Repaid | -19.08M | -8.29M | -1.38M | -890.00K | -26.00K |
| Net Debt Issued (Repaid) | -1.90M | 11.12M | 11.74M | 8.19M | 5.52M |
| Issuance of Common Stock | 19.08M | 17.44M | |||
| Other Financing Activities | -1.49M | -1.49M | |||
| Financing Cash Flow | 15.69M | 27.08M | 11.74M | 10.84M | 5.52M |
| Foreign Exchange Rate Adjustments | 7.00K | -50.00K | -15.00K | -105.00K | 134.00K |
| Net Cash Flow | -372.00K | 11.36M | -148.00K | 92.00K | -5.10M |
| Free Cash Flow | -16.07M | -15.67M | -11.87M | -10.64M | -10.75M |
| Free Cash Flow Margin | -255.06% | -317.27% | -270.42% | -211.01% | -261.42% |
| Free Cash Flow Per Share | -10.88 | -21.63 | -74.74 | -66.98 | -96.15 |
| Levered Free Cash Flow | -22.79M | -12.58M | 2.22M | -2.88M | |
| Unlevered Free Cash Flow | -23.38M | -13.73M | 1.75M | -2.79M | |
| Cash Interest Paid | 344.00K | 259.00K | 1.00K | 1.00K | 2.00K |
| Cash Income Tax Paid | 4.00K | 1.00K | 2.00K | ||
| Change in Working Capital | -3.14M | -3.20M | 963.00K | 3.28M | -1.93M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Market Capitalization | 21.07M | 128.98M | |||
| Enterprise Value | 22.61M | 126.78M | |||
| Last Close Price | 8.35 | 87.50 | |||
| PS Ratio | 3.10 | 26.11 | |||
| PB Ratio | 10.00 | 34.04 | |||
| P/TBV Ratio | 30.70 | 48.40 | |||
| EV/Sales Ratio | 3.34 | 25.66 | |||
| Debt / Equity Ratio | 0.92 | 1.84 | -0.88 | -2.65 | 0.17 |
| Net Debt / Equity Ratio | 0.90 | -0.13 | -0.88 | -2.58 | 0.16 |
| Net Debt / EBITDA Ratio | -0.10 | 0.04 | -1.54 | -0.61 | -0.17 |
| Net Debt / FCF Ratio | -0.10 | 0.03 | -1.75 | -0.86 | -0.17 |
| Asset Turnover | 0.60 | 0.28 | 0.37 | 0.38 | |
| Inventory Turnover | 0.79 | 0.67 | 0.60 | 1.03 | |
| Quick Ratio | 0.09 | 0.43 | 0.02 | 0.10 | 1.26 |
| Current Ratio | 1.02 | 1.11 | 0.28 | 0.95 | 4.04 |
| Return on Equity (ROE) | -398.34% | ||||
| Return on Assets (ROA) | -93.62% | -47.82% | -73.00% | -72.27% | |
| Return on Capital Employed (ROCE) | -910.80% | -344.10% | 59.10% | -717.00% | -89.00% |
| Earnings Yield | -198.49% | -20.94% | |||
| FCF Yield | -82.29% | -12.15% | |||
| Buyback Yield / Dilution | -802.75% | -356.13% | -42.07% |